We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Nanotechnology Provides an Armory of Imaging and Therapeutic Applications

By LabMedica International staff writers
Posted on 08 Sep 2014
Print article
Scientists have created dynamic nanoparticles (NPs) that could provide a range of applications to diagnose and treat cancer. Built on a simple-to-construct polymer base, these particles can be utilized as contrast agents to illuminate tumors for magnetic resonance imaging (MRI) and PET scans or deliver chemo and other therapies to kill tumors. Furthermore, the particles are biocompatible and have shown no toxicity.

The study’s finding were published online August 26, 2014, in Nature Communications. “These are amazingly useful particles,” noted co-first author Dr. Yuanpei Li, a research faculty member in the laboratory of Dr. Kit Lam and colleagues from the University of California (UC) Davis (Sacramento, USA). “As a contrast agent, they make tumors easier to see on MRI and other scans. We can also use them as vehicles to deliver chemotherapy directly to tumors; apply light to make the nanoparticles release singlet oxygen (photodynamic therapy) or use a laser to heat them (photothermal therapy)—all proven ways to destroy tumors.”

Jessica Tucker, program director of Drug and Gene Delivery and Devices at the US National Institute of Biomedical Imaging and Bioengineering, which is part of the National Institutes of Health (NIH; Bethesda, MD, USA), stated that this strategy has the capability to combine both imaging and therapeutic applications in a single platform, which has been problematic to achieve, particularly in an organic, and therefore biocompatible, vehicle. “This is especially valuable in cancer treatment, where targeted treatment to tumor cells, and the reduction of lethal effects in normal cells, is so critical,” she added.

Though these are not the first constructed nanoparticles, these may be the most versatile. Other particles are suitable for some tasks but not others. Non-organic particles, such as quantum dots or gold-based materials, work well as diagnostic tools but have safety problems. Organic probes are biocompatible and can deliver drugs but do not have any imaging or phototherapy applications.

Constructed on a porphyrin/cholic acid polymer, the nanoparticles are simple to make and perform well in the body. Porphyrins are common organic compounds. Cholic acid is produced by the liver. The basic nanoparticles are 21-nm wide. To further stabilize the particles, the researchers added the amino acid cysteine (creating CNPs [carbon nanotube–polymers]), which prevents them from prematurely releasing their therapeutic payload when exposed to blood proteins and other barriers. At 32 nm the CNPs are ideally sized to penetrate tumors, accruing among cancer cells while sparing healthy tissue.

In the study, the scientists evaluated the nanoparticles, both in vitro and in vivo, for a wide range of tasks. On the therapeutic side, CNPs effectively transported anti-cancer drugs, such as doxorubicin. Even when kept in blood for many hours, CNPs only released small amounts of the drug; however, when exposed to light or agents such as glutathione, they readily released their payloads. The ability to precisely control chemotherapy release inside tumors could greatly reduce toxicity. CNPs carrying doxorubicin provided excellent cancer control in animals, with minimal side effects.

CNPs also can be configured to respond to light, producing singlet oxygen, reactive molecules that destroy tumor cells. They can also generate heat when hit with laser light. Significantly, CNPs can perform either task when exposed to a single wavelength of light.

CNPs offer a number of advantages to enhance imaging. They readily chelate imaging agents and can remain in the body for long periods. In animal studies, CNPs congregated in tumors, making them easier to read on an MRI. Because CNPs accumulated in tumors, and not so much in normal tissue, they dramatically enhanced tumor contrast for MRI and may also have potential for PET-MRI scanning applications.

This versatility provides multiple options for clinicians, as they mix and match applications. “These particles can combine imaging and therapeutics,” said Dr. Li. “We could potentially use them to simultaneously deliver treatment and monitor treatment efficacy.”

“These particles can also be used as optical probes for image-guided surgery,” said Dr. Lam. “In addition, they can be used as highly potent photosensitizing agents for intraoperative phototherapy.”

Even though the early findings are promising, there is still a long way to go before CNPs can enter the clinic. The researchers and its collaborators will pursue preclinical studies and, if all goes well, proceed to human trials. Meanwhile, they are thrilled about these capabilities. “This is the first nanoparticle to perform so many different jobs,” concluded Dr. Li. “From delivering chemo, photodynamic and photothermal therapies to enhancing diagnostic imaging, it’s the complete package.”

Related Links:

University of California, Davis


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Unit-Dose Packaging solution
HLX
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.